Orszagos Onkologiai Intezet — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

3 Unique IMPs

N/A Results reported

Phase II

Phase IV

Top indications

2 total

Individualized everolimus therapy in metastatic breast cancer Pending

2023-505590-33-06 Phase II 1 country EVEROLIMUS
Brain cancer and changes in immune system Recruiting

2024-512136-30-00 Phase IV 1 country BEVACIZUMAB

Showing 1–2 of 2 trials